AKYNZEO COMPONENT PALONOSETRON HYDROCHLORIDE | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

AKYNZEO COMPONENT PALONOSETRON HYDROCHLORIDE
Europe

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

pharmacompass-1-m-2026-01-12

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Palonosetron Hydrochloride

Contact Supplier

pharmacompass-2-m-2025-11-03

AKYNZEO COMPONENT PALONOSETRON HYDROCHLORIDE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 21 USDMF, 4 JDMF, 8 EU WC, 4 KDMF, 11 NDC API, 22 Listed Suppliers, $ API Reference Price

40 API Suppliers
21 USDMF
4 JDMF
8 EU WC
4 KDMF
11 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

96 FDF Dossiers, 34 FDA Orange Book, 24 Europe, 2 Canada, 4 Australia, 9 South Africa, 23 Listed Dossiers

96 FDF Dossiers
34 FDA Orange Book
24 Europe
2 Canada
4 Australia
9 South Africa
23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE, SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML), POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL, SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML), INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 300MG;EQ 0.5MG BASE
SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
POWDER;INTRAVENOUS - EQ 235MG BASE/VIAL;EQ 0.25MG BASE/VIAL
SOLUTION;INTRAVENOUS - EQ 235MG BASE/20ML (EQ 11.75MG BASE/ML);EQ 0.25MG BASE/20ML (EQ 0.0125MG BASE/ML)
INJECTABLE;INTRAVENOUS - EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Rochem International Inc, 16 SPI Pharma, 7 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 6 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 CD Formulation, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 2 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 9 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 22 Roquette, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 18 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Thickeners and Stabilizers, 17 Lubricants & Glidants, 16 Taste Masking, 16 Chewable & Orodispersible Aids, 16 Parenteral, 11 Co-Processed Excipients, 11 Film Formers & Plasticizers, 10 Granulation, 9 Coating Systems & Additives, 8 Empty Capsules, 5 Controlled & Modified Release, 3 Solubilizers, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Coloring Agents, 2 Topical, 2 Rheology Modifiers, 1 Soft Gelatin

48 Fillers, Diluents & Binders
18 Disintegrants & Superdisintegrants
18 Direct Compression
17 Thickeners and Stabilizers
17 Lubricants & Glidants
16 Taste Masking
16 Chewable & Orodispersible Aids
16 Parenteral
11 Co-Processed Excipients
11 Film Formers & Plasticizers
10 Granulation
9 Coating Systems & Additives
8 Empty Capsules
5 Controlled & Modified Release
3 Solubilizers
3 Emulsifying Agents
2 API Stability Enhancers
2 Coloring Agents
2 Topical
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

64 News #PharmaBuzz

64 News #PharmaBuzz

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 10 Annual Reports

17 US Medicaid Prescriptions
2 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

9 APIs, 6 FDF Dossiers

9 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 3 Health Canada Patents

36 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

9 Others

9 Others

$ API Ref.Price (USD/KG) : 662,734 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

13 All

01 1Accord Healthcare SLU

02 2Fresenius Kabi Norway AS

03 2HELSINN BIREX PHARMAC.LTD

04 7Helsinn Birex Pharmaceuticals Ltd

05 1Orifarm AS

filter Active Ingredients Reset all filters

13 All

01 2Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride

02 1Netupitant; Palonosetron

03 1Netupitant; Palonosetron Hydrochloride

04 2Netupitant; Palonosetron hydrochloride

05 1Palonosetron

06 6Palonosetronhydroklorid

filter Dosage Form Reset all filters

13 All

01 5Capsule

02 1Concentrate For Solution For Infusion

03 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use

04 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use

05 1Powder For Concentrate For Solution For Infusion

06 4Solution For Injection

filter Country Reset all filters

13 All

01 2Italy

02 8Norway

03 3Sweden

filter Brand Name Reset all filters

13 All

01 6Akynzeo

02 4Aloxi

03 1Palonosetron Accord

04 2Palonosetron Fresenius Kabi

List of Suppliers

Product Main Page

01

HELSINN BIREX PHARMAC.LTD

IPPE

Not Confirmed

HELSINN BIREX PHARMAC.LTD

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Netupitant; Palonosetron

Brand Name : Akynzeo

Dosage Form : Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use

Dosage Strength : 1 cps 300 mg + 0.5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

HELSINN BIREX PHARMAC.LTD

IPPE

Not Confirmed

HELSINN BIREX PHARMAC.LTD

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Palonosetron

Brand Name : Aloxi

Dosage Form : Palonosetron 250Mcg 5Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 250 mcg 5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride

Brand Name : Akynzeo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 235mg/0.25mg

Packaging :

Approval Date : 12/11/2021

Application Number : 20200916000079

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Fosnetupitant Chloride Hydrochloride; Palonosetron Hydrochloride

Brand Name : Akynzeo

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 235mg/0.25mg

Packaging :

Approval Date : 16/03/2020

Application Number : 20181108000049

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Netupitant; Palonosetron Hydrochloride

Brand Name : Akynzeo

Dosage Form : Capsule

Dosage Strength : 300mg/0.5mg

Packaging :

Approval Date : 27/05/2015

Application Number : 20140125000029

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Netupitant; Palonosetron hydrochloride

Brand Name : Akynzeo

Dosage Form : Capsule

Dosage Strength : 300mg; 0.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Not Marketed

Registration Country : Norway

Palonosetronhydroklorid

Brand Name : Aloxi

Dosage Form : Solution For Injection

Dosage Strength : 250mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Palonosetronhydroklorid

Brand Name : Aloxi

Dosage Form : Capsule

Dosage Strength : 500mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Helsinn Birex Pharmaceuticals Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Palonosetronhydroklorid

Brand Name : Aloxi

Dosage Form : Capsule

Dosage Strength : 500mcg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Orifarm AS

IPPE

Not Confirmed

Orifarm AS

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Not Marketed

Registration Country : Norway

Netupitant; Palonosetron hydrochloride

Brand Name : Akynzeo

Dosage Form : Capsule

Dosage Strength : 300mg; 0.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.